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ABST RACT

Hepatitis C virus (HCV) is a pathogenic entity which determines inflammation
and liver damage through complex immune mechanisms. Although progress has
been made in managing the disease course, chronic infection still remains a
significant cause of morbidity and mortality to this day. Because both acute and
chronic infection are often asymptomatic, chronic infection is frequently
diagnosed when its complications have developed. In a small proportion of
cases, the chronic infection does not develop, the immune system managing to
cleanse the body from this silent pathogen in the absence of specific treatment,
a process called spontaneous viral clearance, which occurs rarely, in about 2030 % of cases. A competent immune response that manages to eliminate the
virus from the organism was associated with IL-28B genetic polymorphism,
female gender, young age, which often lead to clinical manifestations of acute
hepatitis after initial exposure. Environmental factors such as limited viral
exposure also play an important role. These factors and the mechanisms
underlying spontaneous clearance are not fully understood but their action is
complementary. In this paper, we review the concept of spontaneous clearance
of HCV and assess the factors that have been associated with this clinical
outcome of the infection.

Introduction
Chronic hepatitis C infection is a chronic hepatopathy
produced by the Hepatitis C Virus, which is characterized
by persistent inflammation of the liver tissue over a period
of more than six months after initial exposure to the virus
[1].
According to epidemiological data made available by
World Health Organization (WHO), in 2015 there were
1,75 million new infected cases (with a global incidence of
23.7/100.000) and an estimated 71 million people living
with chronic HCV worldwide. In 2015 the worldwide
prevalence was 1%. In terms of distribution, the prevalence
of HCV is heterogeneous, with differences throughout
geographical regions, the highest prevalence being met in
The Eastern Mediterranean Region (2.3%), followed by the
European Region (1.5%). In 2015 there were 1.34 million
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deaths due to complications of chronic viral hepatitis, 30%
of these infections having the etiological agent HCV [2].
Although the recognition that another pathogen may
cause chronic hepatitis besides hepatitis A and B virus has
been around for more than half a century, the etiologic
agent of so-called „non- A non- B hepatitis” was first
described only in the late 1980s [3-7].
Hepatitis C virus is a hepatotropic RNA virus that
belongs to the extensive Flaviviridae family, the
Hepacivirus genus [8]. Structurally it is composed of the
viral genome (viral ARN), which is enveloped in the
nucleocapsid and protected by a protein layer.
HCV infection can be acquired through several
pathways: parenteral, sexual, and maternal-fetal, the last
being less common [9]. Once acquired, the acute infection
is developed, which in the majority of cases is
asymptomatic, thus explaining the low rate of early HCV
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diagnosis. In 20-30% of cases due to complex interactions
between host, virus, and environmental factors,
spontaneous clearance (SC) occurs, most often in the first
six months after exposure [10]. Unfortunately, for the vast
majority of cases, the acute infection evolves into a chronic
one which, left untreated, can lead to liver cirrhosis as well
as other complications [11].
Diagnosing HCV is a two-step process: the first one
implies serological presence of HCV antibodies; the
second, after the HCV antibodies are positive, a nucleic
acid test for the virus RNA is needed to confirm the
infection [12].

Discussions
Spontaneous clearance of VHC
The spontaneous clearance of HCV is a rare clinical
event, but which has been observed and objectified in
several specialized studies. As the name implies, it
involves the eradication of the virus in the absence of a
specific treatment. From a serological point of view,
patients who develop SC are characterized by the presence
of anti-HCV antibodies in their serum and by the absence
of HCV-RNA [13].
HCV SC is an incompletely elucidated clinical
outcome determined by the complex interaction between
host, environmental, and viral factors.
1. Host factors
1.1. Interleukin-28B Gene
IL-28B, together with IL-28A and IL-29, represents a
gene cluster located on chromosome 19 that encodes
elements of the immune response. IL-28B stores the
information needed to encode interferon (IFN) λ3.
INF-λ3 belongs to the INF-λ family, together with INFλ1 and INF-λ2, (which are encoded by IL29 and IL28A). λ
interferons are considered type III interferons which play
an essential role in the immune response triggered by a
viral infection, being potent endogenous antiviral
cytokines. They are mainly produced by macrophages in
response to viral stimuli and can inhibit viral protein
synthesis and replication by having similar biological
activity with type I IFN (alpha and beta) [14].
Genome-wide association studies have identified
polymorphism determined by a single nucleotide located at
rs12979860 near the IL-28B gene, making possible three
variants: CC, TT, and CT. The spread of the CC variant
across the globe is heterogeneous, the highest incidence
being among the Asian population [15].
The first associations between the IL-28B genetic
polymorphism and HCV were observed analyzing the
response to IFN-alpha treatment; at that time, patients
presenting the CC subtype had a higher virological
response rate. Currently, interferon treatment is outdated,

but the importance of the IL-28B genetic polymorphism is
not, an impressive number of studies associating the
presence of IL-28B CC subtype with spontaneous
clearance of VHC in the acute phase [16-19].
How the presence of CC genotype is associated with a
better response to HCV infection is not fully known. The
serum of CC positive patients is characterized by higher
levels of IL-28B and higher levels of transaminases than
the serum of CT or TT positive patients, suggesting that
they have a more competent immune response. Several
studies concluded that not only IL-28B levels were
elevated but also IL-29 and IL-28A, implying that the
presence of CC variant may have an impact on the
production of all lambda type IFN [20].
This feature supports the importance of genetic factors
and also genetic variability in the clinical outcome of VHC
infection, patients with the IL-28B CC subtype having a
higher probability of eliminating the virus in the absence
of specific treatment [21].
1.2. Gender
The importance of gender in the clinical outcome of
viral infection is unknown, but it is has been observed,
namely: Spontaneous clearance of HCV has been noticed
more in females than in males; females have a better
response to eradication therapy; in the chronic phase of
infection men have higher levels of HCV RNA than
females; cirrhotic progression occurs more frequent after
menstrual cessation [10, 12-26].
The reason behind this different behavior of the clinical
course is not fully known; some authors believe that sexspecific hormones play a decisive role in this regard [27].
In that matter, it has been shown that 17β-estradiol, an
important constituent of the female endocrine system,
interferes with infection progress by inhibiting viral protein
assembly and virus release from the hepatocyte [28].
A relatively new study concluded that estrogen exerts
its influence even in the primary stages of the infection
process, in that it inhibits virus endocytosis. It
accomplishes this action by Occludin cleavage, a tight
junction protein, but also an HCV receptor found at the
hepatocyte surface [29].
1.3. Ethnicity
The way in which race influences the clinical path of
this disease has not been thoroughly examined, most of the
results deriving from observational studies. However,
taking into account certain genetic varieties found in
different races, such as the genetic polymorphism IL-28B
CC, which has the highest incidence among the Asian
population, we can say that ethnicity is a factor that can
influence the clinical course of infection. Several studies
have shown an association between the higher frequency
of SC in the Aboriginal population, but the underlying
157

Micu Ioan Sergiu et al.

cause remains unclear. An explanation could be found in
the fact that individuals belonging to this ethnicity are
characterized by the ability to produce lower levels of IL10, the cytokine that downregulates several immune
actions, as well as by a more potent activity of "natural
killer" lymphocytes. Of course, all of these facilities are
determined by genetic factors, which remain the subject of
many questions [30,31].
1.4. Symptomatic acute hepatitis
As mentioned above, acute HCV infection is in most
cases asymptomatic. However, when it becomes manifest,
the symptomatology is polymorphic, ranging from
asthenia, anorexia, abdominal pain, jaundice, to severe
forms with liver failure.
Several studies have shown a positive association
between SC and a history of jaundice as a manifestation of
acute infection. Moreover, one study suggested that those
who presented with jaundice as a manifestation of acute
infection have a 3-4 times greater chance of spontaneous
clearance than those who developed asymptomatic
infection [32].
Although the virus exhibits tropism for the liver tissue,
the way it affects the hepatocytes is mainly indirect, via the
host's immune system, which is stimulated by the presence
of surface antigens found in the structure of the viral
envelope. The direct action on the hepatocyte is limited,
insignificant in the pathogenesis of liver injury. In this
sense, the presence of jaundice in the acute phase may
suggest an extensive liver injury, determined by a more
competent immune system that is able to eliminate the
virus from the organism.
1.5. Age
Regarding the relationship between the age of infection
and the spontaneous viral clearance, the data is quite
limited and the conclusions are drawn more indirectly. In
this sense, considering that as the organism gets older, the
chances of developing comorbidities that reduce the
immune system's ability to clear the body of this pathogen
increase (for example, diabetes, cancers, alcohol
consumption, co-infection with other viruses, menopause,
other) and the chances of SC are lower [33].
Studies carried out in young people who developed this
infection due to repeated transfusions for hemophilia
showed that the highest rate of spontaneous clearance was
among the children who got the infection within the first
two years of life, compared to those who got infected after
the age of two [34].
However, given that the children were infected during
transfusions, and that this therapy is weight dependent,
the higher rate of SC in them may have been due to
inoculation of smaller amounts of the pathogen,
158

compared to adults who received larger quantities of
transfused products. The complex relationship between
age and viral SC is not fully understood, and significant
conclusions cannot yet be drawn.
2. Environmental factors
2.1. Frequency of contact with an HCV source
Hepatitis C Virus is a blood-borne virus, which is
transmitted in most cases parenterally, through contact
with contaminated objects. Nowadays the most common
vector of transmission is represented by the instruments
used for drug administration, iatrogenic infection being an
exception.
Therefore, it is understandable why repeated contact
with a contaminated instrument (for example, a needle
used for heroin administration), which has been used by
other infected individuals, is associated with a reduction in
the incidence of SC. In contrast, one time-contact with the
source has been associated with higher odds of viral
clearance, especially among illicit drug users. In that case,
we can safely assume that drug use cessation is positively
associated with this clinical outcome of the infection
[35,36].
2.2. Co-infection with other viruses
Co-infection with other pathogens can alter the course
of HCV infection. Simultaneous infection with
immunosuppressive viruses, for example, Human
Immunodeficiency Virus (HIV), is correlated with almost
zero chance of SC. In contrast to this, an interesting
observation was made in patients with chronic C hepatitis
that developed acute co-infection with Hepatitis B and A
virus, where the rate of spontaneous viral clearance was
increased. The mechanism behind these events is based on
complex immune interactions. It seems that acute
superinfection with the hepatitis A and B virus in patients
already infected with the C virus inhibits not only viral
replication but also stimulates the immune system in a
manner dependent on IFN and TNF alpha, succeeding in C
viral eradication in an impressing proportion of patients
[37-39].
3. Viral factors
HCV is characterized by impressive genetic variability.
Depending on the nucleotide sequences in its RNA, six
major genotypes are described. Within the same genotype,
several subtypes are described, their number exceeding 100
[1,40]. The genotypes have a geographical distribution,
which is why it is difficult to analyze the relationship
between SC and the viral genotype, given the fact that the
studies are performed on patients from a geographical
region, in which a particular type of viral genome
predominates. This fact sustains the research directions for
therapy development according to genotypes particularities
[41-45].

Hepatitis C virus spontaneous clearance

Highlights
✓ Chronic HCV infection is a significant cause of
morbidity and mortality. For the majority of cases,
acute infection evolves into a chronic one which, left
untreated, can lead to liver cirrhosis as well as other
complications.
✓ Spontaneous viral clearance is a rare clinical event
occurring in approximately 20-30% of patients with
HCV infection. Such clearance occurs in most cases
within the first six months after initial exposure but
may occur during the chronic stage of infection.
✓ This favourable clinical outcome is determined by a
true constellation of factors that act in a complex
dynamism.

Conclusions
Spontaneous viral clearance is a rare clinical event
occurring in approximately 20-30% of patients with HCV
infection. SC appears in most cases within the first six
months after initial exposure but may occur during the
chronic stage of infection. It represents an extremely
favourable clinical outcome, which is why patients
consider themselves "lucky", but the course of the disease
is determined not by luck but by a real constellation of
factors that act in a complex dynamism.
We conclude that the presence of the IL-28B variant
type CC, the female sex, the aboriginal and Asian race, the
history of jaundice as manifestation of the acute infection,
young age at exposure, acute superinfection with the
hepatitis A and B virus, and unique contact with a HCV
source are favourable factors in the appearance of
spontaneous viral clearance.
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